Equity Capital Markets

Company · CIK 1601830

RECURSION PHARMACEUTICALS, INC.

CIK1601830 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressUT
ListedRXRX (Nasdaq)
First annual or quarterly report2021-05-12

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-284878
ShelfEffective
 2025-02-122026-10-155
333-264845
ShelfEffective
 2022-05-102024-06-275
333-272281
ShelfEffective
 2023-05-302023-05-301
333-254576
IPOFinal prospectus
 2021-03-222021-04-165

Filings

17
FiledFilingRegistrationAccession
2026-10-15424B5Shelf takedown 333-2848780001601830-26-000134
2026-10-15424B5Shelf takedown 333-2848780001601830-26-000126
2026-02-25424B5Shelf takedown 333-2848780001601830-26-000041
2025-02-28424B5Shelf takedown 333-2848780001193125-25-040678
2025-02-12S-3ASRShelf registered 333-2848780001193125-25-025185
2024-06-27424B5Shelf takedown 333-2648450001601830-24-000093
2024-06-26424B5Shelf takedown 333-2648450001601830-24-000088
2023-08-08424B5Shelf takedown 333-2648450001601830-23-000059
2023-06-09424B5Shelf takedown 333-2648450001601830-23-000042
2023-05-30S-3ASRShelf registered 333-2722810001601830-23-000036
2022-05-10S-3ASRShelf registered 333-2648450001193125-22-146421
2021-04-16424B4Final prospectus 333-2545760001193125-21-119404
2021-04-15EFFECTDeclared effective 333-2545769999999995-21-001450
2021-04-15S-1/AAmendment 333-2545760001193125-21-117033
2021-04-12S-1/AAmendment 333-2545760001193125-21-112364
2021-03-22S-1Registration filed 333-2545760001193125-21-089610
2021-01-26DRSDraft made public 377-041010000950123-21-000614

All filings of this company · CSV